ReShape Lifesciences (RSLS) Q3 2024 Earnings

Aug 14Confirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-6.96
-4.69
-2.43
-0.16

Details

Expected EPS
-6.96
Actual EPS
-4.277964
Surprise EPS
2.68
Surprise Percent
+38.54%

Description

⁨ReShape Lifesciences⁩ (⁦RSLS⁩) has reported earnings of ⁦-4.277964⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts